New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 16, 2014
07:11 EDTWTW, MCO, GEVAHigh option volume stocks: MCO WTW GEVA XSP
News For MCO;WTW;GEVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 27, 2015
07:40 EDTMCOMoody's to hold a conference
2015 Outlook for Asian Sovereigns, Banks & Corporates Conference is being held in Hong Kong on January 27.
January 26, 2015
07:36 EDTGEVASynageva announecs dosing of patients concerned with SBC-103 in Phase 1/2 study
Synageva announced dosing with SBC-103 in patients with mucopolysaccharidosis IIIB has begun as part of a Phase 1/2 study. In addition, the FDA recently granted SBC-103 Fast Track designation. The trial will enroll approximately nine patients, two years of age or greater but less than 12 years of age, with definitive diagnosis of MPS IIIB and developmental delay. Patients will be treated in one of three different dosing cohorts with every other week intravenous administrations of SBC-103 for 24 weeks. Patients who meet qualifying criteria may continue therapy with SBC-103 for an extended treatment period that will last up to 128 weeks. The primary endpoint of the trial is safety and tolerability of intravenous administration of SBC-103 in patients with MPS IIIB. The study will also determine the effects of dosing with SBC-103 on the onset, magnitude, and reversibility of changes in levels of total HS in cerebral spinal fluid, serum, and urine as well as measure the effects of neurocognitive and developmental function and change in brain structures as assessed by magnetic resonance imaging. Exploratory biomarkers, SBC-103 concentration in CSF, MPS IIIB disease characteristics, symptoms, and quality of life will also be measured.
January 23, 2015
07:36 EDTMCOMoody's to hold a conference
Subscribe for More Information
January 22, 2015
07:29 EDTMCOMoody's to hold a conference
Subscribe for More Information
January 16, 2015
07:42 EDTMCOMoody's to hold a teleconference
Proposed Updates to Covered Bond Methodology Teleconference is being held on January 16 at 12 pm. Webcast Link
January 15, 2015
07:25 EDTWTWWeight Watchers price target lowered to $20 from $24 at Credit Suisse
Subscribe for More Information
07:19 EDTMCOMoody's to hold a teleconference
"Rating Structured Finance Securities Update" Teleconference focusing on the proposed changes to the global approach to rating structured finance securities is being held on January 15 at 10 am. Webcast Link
07:15 EDTMCOMoody's to hold a teleconference
Subscribe for More Information
January 14, 2015
08:09 EDTMCOAmerican Enterprise Institute holds a discussion
Peter J. Wallison, Author of "Hidden in Plain Sight: What Really Caused the World’s Worst Financial Crisis and Why It Could Happen Again” discusses the financial crisis of 2008, along with Mark Zandi of Moody's Analytics, Daniel Gallagher of the SEC and John Allison of the Cato Institute in a meeting being held in Washington, D.C. on January 14 at 3 pm. Webcast Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use